BD EXPANDS INNOVATION FOOTPRINT IN BASEL AREA

BD joins Switzerland Innovation Park Basel Area to drive medical innovation and sustainability from its new base at the HORTUS building.

“We're very excited to become part of the international community starting in 2025. At the Main Campus, we'll benefit from sustainable, people-centered architecture and have direct access to other leading companies along the life sciences value chain.”

Derya Oelcer

Business Administration Manager & Project Manager BD

BD (Becton, Dickinson and Company), a global medical technology leader, has strengthened its innovation presence by establishing a base at the Switzerland Innovation Park Basel Area – Main Campus. The new location is housed in the HORTUS building in Allschwil, a state-of-the-art facility that promotes sustainability and collaborative innovation in life sciences.

This move allows BD to engage more directly with Switzerland’s dynamic healthcare ecosystem. It facilitates access to a community of startups, research institutions, and biotech firms that are shaping the future of diagnostics and medical care. The HORTUS building, constructed with energy efficiency and biophilic design principles, aligns with BD’s global sustainability goals and its ambition to support healthier environments.

BD’s local presence is expected to support faster development cycles and new collaborations that can lead to breakthroughs in medical diagnostics and drug delivery technologies. By co-locating with other innovative players, BD enhances its capacity to exchange knowledge, pilot novel concepts, and contribute to regional and global healthcare advancements.

With over 75,000 employees worldwide and a portfolio spanning diagnostics, biosciences, and medical devices, BD’s expansion into the Switzerland InnovationPark Basel Area signals a deepening of its commitment to advancing healthcare through partnerships and responsible innovation.

Diese Stories könnten sie auch interessieren